BCO2
Basic information
Region (hg38): 11:112175510-112224699
Previous symbols: [ "BCDO2" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the BCO2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 30 | 31 | ||||
nonsense | 2 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 31 | 3 | 0 |
Variants in BCO2
This is a list of pathogenic ClinVar variants found in the BCO2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
11-112175611-C-T | High density lipoprotein cholesterol level quantitative trait locus 6 | Uncertain significance (Mar 23, 2024) | ||
11-112175615-T-C | not specified | Uncertain significance (Feb 01, 2023) | ||
11-112175648-C-T | not specified | Likely benign (Nov 10, 2022) | ||
11-112175666-C-T | not specified | Uncertain significance (Aug 11, 2022) | ||
11-112179356-C-T | not specified | Uncertain significance (Oct 03, 2022) | ||
11-112179472-G-C | not specified | Uncertain significance (Dec 22, 2023) | ||
11-112193478-A-G | not specified | Uncertain significance (Jun 01, 2023) | ||
11-112193582-C-G | not specified | Uncertain significance (Apr 19, 2023) | ||
11-112193598-A-G | not specified | Uncertain significance (Mar 07, 2023) | ||
11-112193911-C-T | not specified | Uncertain significance (Mar 20, 2023) | ||
11-112194687-C-G | not specified | Uncertain significance (Apr 25, 2023) | ||
11-112194731-A-C | not specified | Uncertain significance (Dec 14, 2022) | ||
11-112194746-G-A | not specified | Uncertain significance (Sep 13, 2023) | ||
11-112194751-A-C | Likely benign (Dec 01, 2022) | |||
11-112199706-CTATAAGGT-C | Uncertain significance (Feb 08, 2023) | |||
11-112199720-G-A | not specified | Uncertain significance (Dec 16, 2023) | ||
11-112199792-C-G | not specified | Uncertain significance (Jan 31, 2023) | ||
11-112200673-T-C | not specified | Uncertain significance (Nov 15, 2021) | ||
11-112200690-C-T | not specified | Uncertain significance (Jan 22, 2024) | ||
11-112200718-G-A | not specified | Uncertain significance (Aug 16, 2022) | ||
11-112200739-C-T | not specified | Uncertain significance (Dec 09, 2023) | ||
11-112202056-G-A | not specified | Uncertain significance (Nov 15, 2021) | ||
11-112202065-C-T | not specified | Uncertain significance (Jul 30, 2023) | ||
11-112202149-C-G | not specified | Uncertain significance (Jul 19, 2023) | ||
11-112213757-A-T | not specified | Uncertain significance (Sep 16, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
BCO2 | protein_coding | protein_coding | ENST00000357685 | 12 | 49233 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
3.78e-18 | 0.0100 | 125412 | 0 | 336 | 125748 | 0.00134 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.410 | 295 | 315 | 0.935 | 0.0000161 | 3813 |
Missense in Polyphen | 113 | 121.95 | 0.9266 | 1602 | ||
Synonymous | 0.593 | 102 | 110 | 0.928 | 0.00000523 | 1099 |
Loss of Function | 0.348 | 28 | 30.1 | 0.931 | 0.00000163 | 339 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0116 | 0.0117 |
Ashkenazi Jewish | 0.00228 | 0.00228 |
East Asian | 0.00147 | 0.00147 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.000467 | 0.000457 |
Middle Eastern | 0.00147 | 0.00147 |
South Asian | 0.000654 | 0.000653 |
Other | 0.000977 | 0.000978 |
dbNSFP
Source:
- Function
- FUNCTION: Asymmetrically cleaves beta-carotene at the 9',10' double bond resulting in the formation of beta-apo-10'-carotenal and beta-ionone. Besides beta-carotene, lycopene is also oxidatively cleaved. The apocarotenals formed by this enzyme may be the precursors for the biosynthesis of retinoic acid or exert unknown physiological effects. {ECO:0000269|PubMed:21106934}.;
- Pathway
- Vitamin A and Carotenoid Metabolism;Signaling by GPCR;Signal Transduction;Metabolism of fat-soluble vitamins;Metabolism;Metabolism of vitamins and cofactors;Retinoid metabolism and transport;G alpha (i) signalling events;Visual phototransduction;GPCR downstream signalling
(Consensus)
Recessive Scores
- pRec
- 0.109
Intolerance Scores
- loftool
- rvis_EVS
- 1.69
- rvis_percentile_EVS
- 96.41
Haploinsufficiency Scores
- pHI
- 0.0499
- hipred
- N
- hipred_score
- 0.146
- ghis
- 0.411
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.330
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Bco2
- Phenotype
- immune system phenotype; liver/biliary system phenotype; reproductive system phenotype; hematopoietic system phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); endocrine/exocrine gland phenotype; cellular phenotype; homeostasis/metabolism phenotype;
Gene ontology
- Biological process
- retinoid metabolic process;carotenoid metabolic process;carotene metabolic process;carotene catabolic process;xanthophyll metabolic process;retinoic acid metabolic process;retinal metabolic process;regulation of mitochondrial membrane potential;oxidation-reduction process;regulation of reactive oxygen species metabolic process
- Cellular component
- mitochondrion;mitochondrial matrix
- Molecular function
- beta-carotene 15,15'-monooxygenase activity;retinal isomerase activity;carotenoid dioxygenase activity;oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen;metal ion binding;beta,beta-carotene-9',10'-cleaving oxygenase activity